MB "Pharmafina" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 1,571 |
| - |
| 1,512 |
| 1,512 |
| - |
| 100.00 |
| 96.24 |
| 1,514 |
| 59 |
| 0 |
| 1,573 |
| 2024 |
|---|
| 197,642 |
| - |
| 151,939 |
| 144,896 |
| - |
| 100.00 |
| 73.31 |
| 146,409 |
| 7,043 |
| 0 |
| 153,452 |
| 2025 |
|---|
| 292,334 |
| - |
| 237,870 |
| 224,345 |
| - |
| 100.00 |
| 76.74 |
| 190,754 |
| 13,525 |
| 699 |
| 203,580 |
Register and
explore Okredo data| 2025 |
|---|
| 292,334 |
| - |
| 237,870 |
| 224,345 |
| - |
| 100.00 |
| 76.74 |
| 190,754 |
| 13,525 |
| 699 |
| 203,580 |
Register and
explore Okredo dataTurnover (€)
2025
Turnover (€)
292,334 €48 % *
Sales per employee (€)
-Profit before tax (€)
237,870 €57 % *
Net Profit (€)
224,345 €55 % *
Profit per employee (€)
-Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
76.74 %4.68 % *
Equity (€)
190,754 €30 % *
Amounts Payable And Liabilities (€)
13,525 €92 % *
Non-current Assets (€)
699 €- *
CurrentAssets (€)
203,580 €33 % *
